Cargando…

An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review

Vulvar cancer represents approximately 3%–5% of all gynecological malignancies. Squamous cell carcinoma is the most frequent histotype, whereas melanomas, adenocarcinomas, basal cell carcinomas, and sarcomas are much less common. Intestinal-type adenocarcinoma is a rare variant of vulvar carcinoma w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musella, Angela, Marchetti, Claudia, Salerno, Laura, Vertechy, Laura, Iadarola, Roberta, Pecorella, Irene, Panici, Pierluigi Benedetti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836303/ https://www.ncbi.nlm.nih.gov/pubmed/24307962 http://dx.doi.org/10.1155/2013/427141

Ejemplares similares

Nonabsorbable suture granuloma mimicking ovarian cancer recurrence at combined positron emission tomography/computed tomography evaluation: a case report
por: Imperiale, Ludovica, et al.
Publicado: (2014)

Vulvar Malignancy in Neurofibromatosis Syndrome
por: Musella, Angela, et al.
Publicado: (2013)

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
por: Marchetti, Claudia, et al.
Publicado: (2014)

Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
por: Marchetti, Claudia, et al.
Publicado: (2018)

The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients
por: Di Donato, Violante, et al.
Publicado: (2018)

Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: A case report
por: Musella, Angela, et al.
Publicado: (2020)

Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis
por: Marchetti, Claudia, et al.
Publicado: (2016)

Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
por: Mazzotta, Marco, et al.
Publicado: (2021)

Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article
por: Niu, Yizhen, et al.
Publicado: (2018)

Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?
por: Klavans, Madison R., et al.
Publicado: (2020)

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
por: Marchetti, Claudia, et al.
Publicado: (2019)

“Intestinal-Type” Vulvar Adenocarcinoma: A Review of the MITO Rare Tumors Group
por: Dellino, Miriam, et al.
Publicado: (2022)

Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?
por: Richter, Hannah, et al.
Publicado: (2018)

Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma
por: Velandia, Carlos, et al.
Publicado: (2018)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Neoadjuvant chemotherapy for high‐risk prostatic adenocarcinoma
por: Brunner, Robert, et al.
Publicado: (2019)

Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
por: Seo, Dongjin, et al.
Publicado: (2023)

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
por: Marchetti, Claudia, et al.
Publicado: (2014)

First case of isolated vaginal metastasis from breast cancer treated by surgery
por: Bellati, Filippo, et al.
Publicado: (2012)

Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
por: Izadi, Fereshteh, et al.
Publicado: (2021)

Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab
por: Dubus, Margaux, et al.
Publicado: (2023)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Prostatic tissue: an unexpected finding in a mature ovarian teratoma: Case report and systematic literature review
por: Pecorella, Irene, et al.
Publicado: (2021)

Unexpected presentation of accessory breast: vulvar accessory breast tissue: a case report
por: Mansouri, Ghazal, et al.
Publicado: (2023)

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
por: Arbore, Giuseppina, et al.
Publicado: (2023)

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy
por: Rossi, Gemma, et al.
Publicado: (2022)

Fertility preservation in gynaecologic cancers
por: De Felice, Francesca, et al.
Publicado: (2018)

Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials
por: Marchetti, Claudia, et al.
Publicado: (2015)

Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN(®) in combination with chemotherapy
por: Kumar, Chaitanya, et al.
Publicado: (2019)

A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
por: Atiq, Saad, et al.
Publicado: (2021)

Late aortic lymphocele and residual ovary syndrome after gynecological surgery
por: Pastore, Maria, et al.
Publicado: (2007)

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.
por: Scambia, G., et al.
Publicado: (1995)

Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
por: De Felice, Francesca, et al.
Publicado: (2015)

Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
por: Bugiantella, W, et al.
Publicado: (2009)

Neoadjuvant chemotherapy in well-differentiated fetal adenocarcinoma: a case report
por: Lkhoyaali, Sihame, et al.
Publicado: (2014)

Identification of Sensitivity Predictors of Neoadjuvant Chemotherapy for the Treatment of Adenocarcinoma of Gastroesophageal Junction
por: Li, Shoumiao, et al.
Publicado: (2017)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
por: You, Chao, et al.
Publicado: (2017)

Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy
por: Miura, Satomi, et al.
Publicado: (2020)

New strategy in hemorrhagic gastric cancer: A case report of complete pathological remission after neoadjuvant chemotherapy
por: Zhou, Yuhang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b4c0pge6nbqh85l4r1aiufrvvn